Order Article Reprints

Maeda Y, Motoyama K, Nishiyama R, Higashi T, Onodera R, Nakamura H, Takeo T, Nakagata N, Yamada Y, Ishitsuka Y, et al. In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease. Nanomaterials. 2019; 9(5):802. https://doi.org/10.3390/nano9050802

Maeda, Yuki, Keiichi Motoyama, Rena Nishiyama, Taishi Higashi, Risako Onodera, Hideaki Nakamura, Toru Takeo, Naomi Nakagata, Yusei Yamada, Yoichi Ishitsuka, and et al. 2019. "In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease" Nanomaterials 9, no. 5: 802. https://doi.org/10.3390/nano9050802

Maeda, Y., Motoyama, K., Nishiyama, R., Higashi, T., Onodera, R., Nakamura, H., Takeo, T., Nakagata, N., Yamada, Y., Ishitsuka, Y., Kondo, Y., Irie, T., Era, T., & Arima, H. (2019). In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease. Nanomaterials, 9(5), 802. https://doi.org/10.3390/nano9050802